Physician Investigator (Cl) Neurology, Mass General Research Institute

Professor of Neurology Harvard Medical School

Clinical Associate Neurology, Massachusetts General Hospital

MD University of Toronto 1994

age of onset; demyelinating autoimmune diseases, cns; demyelinating diseases; encephalomyelitis, acute disseminated; encephalomyelitis, autoimmune, experimental; immunoglobulin fc fragments; multiple sclerosis; multiple sclerosis, chronic progressive; multiple sclerosis, relapsing-remitting; nerve degeneration; neuromyelitis optica

Dr. Tanuja Chitnis is a Professor of Neurology at Harvard Medical School. She cares for adults and children with multiple sclerosis and neuroimmunological disorders. She directs the Partners Pediatric Neuroimmunology and Multiple Sclerosis Center at the Massachusetts General Hospital and serves on the steering committee of several national and international boards and committees for MS research and management, including positions of the Chair of the International Pediatric MS Study Group (IPMSSG) (2010-2018), Executive Committee of the U.S. Network of Pediatric MS Centers (2006-), and ACTRIMS forum meetings co-chair (2018-2020). Additionally, she serves as the Director of the Translational Neuroimmunology Research Center (TNRC) and the Comprehensive Longitudinal Investigations in MS at Brigham (CLIMB Study) at the Ann Romney Center, Brigham and Women’s Hospital.  Dr. Chitnis leads a neuroimmunology laboratory group, clinical research and database team, biostatistics and bioinformatics-analytics group, with the goal of identifying new biomarkers, algorithms and therapeutic targets with the goal of bench to bedside translation for neuroimmunological diseases. Dr. Chitnis has led several clinical trials in MS including recent phase III trials in pediatric MS, including the PARADIGMS study which led to the first FDA approved treatment for pediatric multiple sclerosis. She has published over 250 peer reviewed articles in the neuroimmunological and demyelinating diseases field, and she has received funding awards from the Department of Defense, NIH, National MS Society, and other foundations to support her research.